Table 5 Subgroup analyses comparing IJV versus SCVa
Group | TIVAD-related infections | Catheter-related thrombotic complications | Total major mechanical complications | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | OR (95Â % CI) | I2(%) | P heterogeneity | N | OR (95Â % CI) | I2(%) | P heterogeneity | N | OR (95Â % CI) | I2(%) | P heterogeneity | |
Overall | 11 | 0.71 (0.48–1.04) | 0.0 | 0.963 | 11 | 0.76 (0.38–1.51) | 30.2 | 0.159 | 11 | 0.38 (0.24–0.61) | 31.6 | 0.147 |
Use of antibiotic prophylaxis | ||||||||||||
Yes | 3 | 0.69 (0.27–1.76) | 0.0 | 0.611 | NA | NA | NA | NA | NA | NA | NA | NA |
No | 2 | 0.69 (0.39–1.24) | 0.0 | 0.618 | NA | NA | NA | NA | NA | NA | NA | NA |
Use of ultrasound guidance | ||||||||||||
Yes | 1 | 0.40 (0.02–6.41) | NA | NA | 1 | 1.00 (0.19–5.23) | NA | NA | 1 | 0.39 (0.08–1.98) | NA | NA |
No | 6 | 0.76 (0.47–1.24) | 0.0 | 0.798 | 5 | 0.44 (0.18–1.05) | 0.0 | 0.860 | 6 | 0.38 (0.18–0.79) | 46.3 | 0.098 |
Age Group | ||||||||||||
< 18 yr | 1 | 0.50 (0.14–1.80) | NA | NA | 1 | 0.41 (0.02–10.40) | NA | NA | 1 | 0.27 (0.10–0.76) | NA | NA |
≥ 18 yr | 3 | 0.44 (0.16–1.22) | 0.0 | 0.972 | 4 | 1.13 (0.28–4.61) | 56.8 | 0.073 | 3 | 0.61 (0.15–2.56) | 56.5 | 0.100 |